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Summary
What is already known on this topic?
Substantial racial, ethnic, and geographic disparities exist in diabetes pre-
valence, likely attributable to differences in the age of onset of diabetes
and health outcomes among different subgroups.
What is added by this report?
In New York City, racial and ethnic minority populations have a higher pre-
valence of diabetes than nonminority populations at the recommended
screening age of 45. The average age of patients with type 2 diabetes in
some neighborhoods is more than a decade younger than in other neigh-
borhoods.
What are the implications for public health practice?
These findings suggest the need to target efforts to prevent and diagnose
diabetes in specific geographic areas.
Abstract
Introduction
Although screening for diabetes is recommended at age 45, some
populations may be at greater risk at earlier ages. Our objective
was to quantify age disparities among patients with type 2 dia-
betes in New York City.
Methods
Using all-payer hospital claims data for New York City, we per-
formed a cross-sectional analysis of patients with type 2 diabetes
identified from emergency department visits during the 5-year
period 2011–2015. We estimated type 2 diabetes prevalence at
each year of life, the age distribution of patients stratified by dec-
ade, and the average age of patients by sex, race/ethnicity, and
geographic location.
Results
We identified 576,306 unique patients with type 2 diabetes. These
patients represented more than half of all people with type 2 dia-
betes in New York City. Patients in racial/ethnic minority groups
were on average 5.5 to 8.4 years younger than non-Hispanic white
patients. At age 45, type 2 diabetes prevalence was 10.9% among
non-Hispanic black patients and 5.2% among non-Hispanic white
patients. In our geospatial analyses, patients with type 2 diabetes
were on average 6 years younger in hotspots of diabetes-related
emergency department use and inpatient hospitalizations. The av-
erage age of patients with type 2 diabetes was also 1 to 2 years
younger in hotspots of microvascular diabetic complications.
Conclusion
We identified profound age disparities among patients with type 2
diabetes in racial/ethnic minority groups and in neighborhoods
with poor health outcomes. The younger age of these patients may
be due to earlier onset of diabetes and/or earlier death from diabet-
ic complications. Our findings demonstrate the need for geograph-
ically targeted interventions that promote earlier diagnosis and bet-
ter glycemic control.
Introduction
Poor glycemic control, microvascular diabetic complications, and
frequent diabetes-related hospital use have been shown to cluster
in the same neighborhoods (1,2). Therefore, certain communities
have poorer health outcomes, higher morbidity and mortality, and
a higher proportion of the financial burden associated with dia-
betes. Many of these areas have a higher proportion of racial/eth-
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nic minority residents, including non-Hispanic black and Hispanic
residents (3). Their higher burden of diabetes is attributable in part
to socioeconomic status, environmental influences, and health be-
haviors (4–7).
Diabetes prevention before onset and optimal management after
diagnosis are critical to reduce these disparities (8,9). The Ameri-
can Diabetes Association recommends screening for type 2 dia-
betes starting at age 45 (10). The guidelines also suggest that earli-
er screening of persons at high risk may be warranted as a part of
ongoing medical care (11). These recommendations are complic-
ated in clinical practice because many people who are at high risk
for diabetes also have limited access to medical care. In these pop-
ulations, diagnosis may be delayed, which may have important im-
plications for the development of long-term diabetic complica-
tions and early diabetes-related death (12).
The objective of this study was to investigate the age distribution
of patients with type 2 diabetes in light of American Diabetes As-
sociation screening recommendations at age 45. Previous studies
showed that claims data can be used to estimate the prevalence of
diabetes and its  associated complications and that  claims data
compare favorably with traditional health survey estimates (2,13).
These studies demonstrated that the demographic distribution of
unique emergency patients is similar to the demographic distribu-
tion of census estimates of the general population and is thus use-
ful for tracking diabetes cross-sectionally for a large proportion of
the population in a given geographic area (2).
In this study, we used all-payer claims data to analyze the age of
patients with type 2 diabetes in New York City and to stratify pa-
tients by sex, race, and ethnicity. We also examined the average
age of patients with type 2 diabetes living in previously identified
“hotspots” (ie, geospatial clusters) of diabetes-related hospital use.
These rates of hospital use are important because diabetes-related
emergency department visits and inpatient hospitalizations ac-
count for nearly half of the large financial burden associated with
diabetes (14). We also analyzed the average age of patients with
type 2 diabetes in previously identified hotspots of macrovascular
(eg, myocardial infarction and stroke) versus microvascular (eg,
end-stage renal disease and non-traumatic lower extremity ampu-
tations) diabetic complications because they have significant con-
sequences for patient outcomes (15).
Methods
Study design
Nearly 800,000 people in New York City have type 2 diabetes
(16). To study the age distribution of these patients, we first as-
sessed the prevalence of type 2 diabetes among patients in New
York City who had at least 1 emergency department visit from
2011 through 2015 (2). We then calculated both the average age of
patients with type 2 diabetes and the proportion of these patients in
10-year age groups (ie, 10–19, 20–29, 30–39, and so on). We then
stratified these measures by sex, race, and ethnicity. We used geo-
graphic analysis to identify hotspots of both diabetes-related hos-
pital use and diabetic complications, and then we examined the
age of patients with type 2 diabetes living in these areas (17).
Data sources
We obtained data on emergency department visits and inpatient
hospitalizations from the Statewide Planning and Research Co-
operative System (SPARCS), which is an all-payer claims data-
base administered by the New York State Department of Health
(18). We used these data to analyze the age of patients with type 2
diabetes and calculate the rate of diabetes-related emergency de-
partment visits and inpatient hospitalizations. We calculated these
hospital use rates per resident by using tract-level 5-year estimates
from  the  US  Census  Bureau’s  American  Community  Survey
2011–2015 (19). We used SPARCS data also to estimate the pre-
valence of diabetic complications among patients with type 2 dia-
betes (1).
Main outcome
Our main outcome was the age of patients with type 2 diabetes,
which  we assessed  among unique  patients  who had  at  least  1
emergency department visit from 2011 through 2015. For patients
with more than 1 emergency department visit during the 5-year
period, we selected the age at a randomly selected visit. We used
unique identifiers from the SPARCS database to account for mul-
tiple visits to different hospitals by the same person. We included
patients aged 10 to 100 who had a home address that geocoded to
a census tract in New York City. We then analyzed age as an aver-
age and also by the proportion of patients in each 10-year age
group.
Associated health outcomes
To analyze associations between our main outcome and key dia-
betes-related health measures, we analyzed the average age of pa-
tients with type 2 diabetes in geographic areas with a high preval-
ence of diabetic complications. We identified the proportion of pa-
tients with type 2 diabetes who also had a concurrent diagnosis of
myocardial infarction, ischemic stroke, end-stage renal disease, or
non-traumatic lower extremity amputation (Box) (1). We calcu-
lated the estimated prevalence of these conditions among unique
patients who visited an emergency department at least once dur-
ing the study period and had a primary or secondary diagnosis of
type 2 diabetes during any of their previous emergency depart-
ment visits.
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Box. ICD-9-CM and ICD-10-CM Codes for Type 2 Diabetes and Severe
Diabetic Complicationsa
Diagnosis ICD-9-CM Code ICD-10-CM Code
Type 2 diabetes 250.x1, 250.x3 E11
Myocardial infarction 410, 412 I21, I22, I23, I25.2












Abbreviation: CM, Clinical Modification; ICD, International Classification of
Diseases.
a ICD-9-CM and ICD-10-CM are the official systems of assigning codes to
diagnoses and procedures associated with hospital use in the United
States (20,21).
We also analyzed measures of diabetes-related hospital use, which
has been estimated to represent nearly half of the direct financial
costs associated with diabetes and geographically overlaps with
areas of poor glycemic control as measured by hemoglobin A1c
(14,22). Here, we calculated the per capita rates of diabetes-specif-
ic emergency department visits and inpatient hospitalizations sep-
arately. To create these 2 measures, we determined the average an-
nual number of emergency department visits or inpatient hospital-
izations with a primary (not secondary) diagnosis for type 2 dia-
betes, then divided that figure by the total number of residents at
all  ages  as  estimated  by  the  American  Community  Survey
2011–2015 for each census tract (19).
Statistical analysis
We analyzed the average age and prevalence of patients with type
2  diabetes  by  using  standard  descriptive  statistics.  We  also
mapped the average age of patients with type 2 diabetes by census
tract and grouped the range of average ages into deciles. To identi-
fy geographic hotspots and coldspots of diabetic complications
and diabetes-related health care use, we used the Getis-Ord Gi*
statistic to find significant geographic clustering (23). We used the
adjacent neighboring census tracts that shared a border (first-order
queen contiguity) to identify local clusters where our estimates of
diabetic complications and diabetes-related health care use were
higher or lower than would be expected by chance. This analysis
was row-standardized to account for variation in the number of
neighboring census tracts across New York City. We then used a t
test to compare the average age of patients with type 2 diabetes
among census tracts identified as hotspots with the average of pa-
tients with type 2 diabetes among census tracts identified as cold-
spots for the diabetes-related health outcomes of interest.
In our analyses, we excluded 57 of 2,168 census tracts (2.6%) with
a total population estimate of less than 100 people to limit the bias
of areas with low population counts (mostly parks and airports).
We also excluded 28 of the 2,168 census tracts (1.3%) with fewer
than 30 patients that were identified as having type 2 diabetes to
limit the bias of areas with an insufficient number of observations
to provide an average age across patients with diabetes (1). To ac-
count for multiple comparisons among the 4 measures of diabetic
complications and the 2 measures of diabetes-related health care
use, we used a Bonferroni correction to adjust our α level, which
corresponded to a P value of .008.
We performed statistical analyses in Stata 14.2 (StataCorp LLC).
We created maps by using ArcGIS Desktop 10.3.1 (Esri), and we
used GeoDa 1.8.14 (Center for Spatial Data Science at the Uni-
versity of Chicago) for geospatial analyses. Our study protocol
was approved by the institutional review board at the New York
University School of Medicine.
Results
We identified 576,306 unique patients aged 10 to 100 who had
visited an emergency department at least once from 2011 through
2015 and had a diagnosis of type 2 diabetes. Thus, our population
sample identified more than half of people with type 2 diabetes in
New York City. The age and sex distributions of our study popula-
tion were similar to the distributions of the population in New
York City as described by census data. However, the proportion of
people who were non-Hispanic black, publicly insured, or unin-
sured was higher among unique emergency department patients
than among the population in New York City (Table).
Estimated prevalence at specific ages by sex, race,
and ethnicity
The estimated prevalence of type 2 diabetes increased with age
from 0.1% among emergency  department  patients  aged  10  to
34.2%  among  patients  aged  78.  Peak  prevalence  was  higher
among non-Hispanic black patients, at 43.0%, than among non-
Hispanic white patients, at 25.7%. Among all emergency depart-
ment patients aged 25 or older, the prevalence of type 2 diabetes
was higher among racial/ethnic minority patients than among non-
Hispanic white patients of the same age (Figure 1). Differences by
sex were not large: male patients had a 1- to 2-percentage point
higher prevalence of type 2 diabetes than female patients between
the ages of 40 and 75.
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Figure 1. Estimated prevalence and age distribution of patients with type 2
diabetes by race/ethnicity among 576,306 unique patients aged 10 to 100
years who had visited an emergency department at least once from 2011
through 2015 in New York City. Data source: New York State Department of
Health Statewide Planning and Research Cooperative System (18).
The estimated prevalence of type 2 diabetes among non-Hispanic
white patients aged 45 was 5.2%. Among non-Hispanic black pa-
tients aged 45, the prevalence of type 2 diabetes was 10.9%, more
than twice as high as that for non-Hispanic white patients. Among
non-Hispanic black patients,  the prevalence of type 2 diabetes
reached 5.2% by age 37 or 38. In addition, 9.4% of Hispanic pa-
tients and 10.1% of Asian patients had diabetes at age 45. The pro-
portion of patients with type 2 diabetes who were younger than 45
was 6.5% among non-Hispanic white patients, 14.0% among non-
Hispanic  black  patients,  15.7% among Hispanic  patients,  and
10.4% among Asian patients.
Age distribution by sex, race, and ethnicity
The average age of male patients with type 2 diabetes was 2.6
years younger than the average age of female patients. This differ-
ence was most pronounced among non-Hispanic white patients, at
4.4 years, and the least pronounced among Asian patients, at 1.5
years. The average age of non-Hispanic white patients with type 2
diabetes was 68.8. Non-Hispanic black patients were on average
8.3 years younger, Hispanic patients were 8.5 years younger, and
Asian patients were 5.5 years younger.
Analyzing the age distribution by decades, 22.8% of non-Hispan-
ic white patients with type 2 diabetes were aged 60 to 69, fol-
lowed closely by non-Hispanic white patients aged 70 to 79, at
22.6%. In contrast, the highest proportion of non-Hispanic black
patients with type 2 diabetes was aged 50 to 59. They represented
24.8% of all non-Hispanic black patients with type 2 diabetes, fol-
lowed closely by those aged 60 to 69, at  23.2%. However,  we
found steep declines in subsequent decades. Only 17.4% of non-
Hispanic black patients with type 2 diabetes were aged 70 to 79,
and only 9.6% were aged 80 to 89. We observed similar trends
among  Hispanic  and  Asian  patients,  although  declines  were
slightly less steep among Asian patients (Figure 2).
Figure 2. Age distribution by sex, race, and ethnicity among patients with type
2 diabetes among 576,306 unique patients aged 10 to 100 years who had
visited an emergency department at least once from 2011 through 2015 in
New York City. Data source: New York State Department of Health Statewide
Planning and Research Cooperative System (18).
Geographic distribution of average age
We found an almost 12-year difference in the average age of pa-
tients with type 2 diabetes between the census tracts at the 10th
and 90th percentiles. Excluding census tracts with low population
counts, the lowest decile had an average age of 57.1 or younger
(Figure 3). The highest decile had an average age of 68.8 or older.
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Figure 3. Average age of patients with type 2 diabetes, by census tract, among
576,306 unique patients aged 10 to 100 years who had visited an emergency
department at least once from 2011 through 2015 in New York City. Data
source:  New  York  State  Department  of  Health  Statewide  Planning  and
Research Cooperative System (18).
Average age and associated health outcomes
Among the 2,083 census tracts analyzed in our study, we identi-
fied several geographic clusters of diabetes-related hospital use
and diabetic complications. Patients with type 2 diabetes in census
tracts identified as hotspots of diabetes-related emergency depart-
ment use were an average of 5.9 years younger than patients in
coldspots (P < .001). Similarly, patients with type 2 diabetes were
an average of 5.8 years younger in hotspots of diabetes-related in-
patient hospitalizations than patients in coldspots (P < .001).
For microvascular diabetic complications, patients with type 2 dia-
betes in hotspots of end-stage renal disease were 2.2 years young-
er than patients in coldspots (P < .001). Patients with type 2 dia-
betes in hotspots of non-traumatic lower extremity amputations
were 1.5 years younger than patients in coldspots (P = .002). For
macrovascular complications of diabetes, the age trend was re-
versed. Patients with type 2 diabetes in hotspots of myocardial in-
farction were 5.7 years older than patients in coldspots (P < .001).
Similarly, patients with type 2 diabetes in hotspots of ischemic
stroke were 3.8 years older than patients in coldspots of these
complications.
Discussion
Our study analyzed the age distribution of patients with type 2 dia-
betes in New York City and found that the average age of these
patients was younger in hotspots of diabetes-related emergency
department visits and inpatient hospitalizations. We further found
that the average age of patients with type 2 diabetes was younger
in areas identified as hotspots of microvascular (but not macrovas-
cular) diabetic complications. We observed substantial disparities
in the age of patients with type 2 diabetes when stratified by sex,
race, and ethnicity. These findings suggest that the age of patients
with type 2 diabetes may play a role in the high costs, morbidity,
and mortality associated with type 2 diabetes.
Previous studies demonstrated that an earlier age of onset results
in a higher risk of diabetic complications (24,25). Data obtained in
a study linking duration of diagnosis with diabetes-related out-
comes found an interaction between the duration of diabetes and
the risk of microvascular events, but not macrovascular events
(26). The study also found that this effect was greatest at a young-
er rather than older age. Our own study found a similar pattern,
whereby microvascular diabetic complications were associated
with a younger average age of patients with type 2 diabetes. In
contrast, macrovascular diabetic complications were associated
with an older average age.
These findings may speak to distinct subpopulations of patients
with type 2 diabetes that are demographically different and geo-
graphically separate and face disparate clinical trajectories of long-
term diabetic complications. Other studies also established a link
between higher rates of microvascular complications and the level
of glycemic control when measuring HbA1c (27). The geographic
distribution of younger average age among patients with type 2
diabetes in our study was similar to the geographic distribution in
a recently published map of poor glycemic control in New York
City  (21).  These  wide  disparities  in  diabetes  burden  may  be
largely driven by a subpopulation of patients who have an earlier
age of onset, have poorer glycemic control, experience more mi-
crovascular complications than macrovascular complications, and
die at a much earlier age.
In  our  study,  the  distribution  of  patients  with  type  2  diabetes
across age decades varied substantially by race and ethnicity. The
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highest  proportion (not prevalence) of non-Hispanic black pa-
tients with type 2 diabetes were in their 50s: almost one-quarter
(24.8%)  were  in  their  50s,  nearly  a  decade  younger  than  the
highest proportion (22.8%) of non-Hispanic white patients, who
were in their 60s. Several factors might explain these disparities in
age distribution. First, as our prevalence estimates demonstrate, ra-
cial/ethnic minority patients develop type 2 diabetes at a younger
age than non-racial/ethnic minority patients. Second, racial/ethnic
minority patients with type 2 diabetes might be dying earlier of
either diabetic complications or other causes. Although diabetes
prevalence is still high among racial/ethnic minority patients at
older ages, our most startling finding was the low proportion of ra-
cial/ethnic minority patients with type 2 diabetes who were alive
in their 80s and 90s.
The current standards for type 2 diabetes screening do not recom-
mend community-based screening (28).  The concerns cited in
these recommendations are that people identified through com-
munity-based screening as having diabetes may not seek or have
access to appropriate follow-up and that community-based testing
may be poorly targeted (10,29). The challenge in these recom-
mendations is that the populations at highest risk of type 2 dia-
betes are often the same groups that do not have a regular source
of medical care (30). Our maps of New York City identified areas
with the youngest average age of patients with type 2 diabetes,
which are some of the same neighborhoods where people report a
lack of medical care (31). These communities may be affected by
cultural health behaviors or local conditions (eg, poor food envir-
onment) that worsen these disparities,  but these behaviors and
conditions might also provide opportunities for intervention (32).
Data on residential addresses might enable identification of specif-
ic  areas  (eg,  block  or  block  groups)  where  interventions  are
needed most.
Our study has several limitations. The fidelity of certain variables
in the claims data can vary by hospital (eg, by ownership, level of
care, or specialty designations). Certain hospitals are less reliable
than others at coding patients as having diabetes. However, these
institutions tend to be public hospitals that provide care for a high-
er proportion of racial/ethnic minority patients; thus, this unreliab-
ility would bias our study toward the null. In addition, certain hos-
pitals have historically been inaccurate in coding race and ethni-
city categories, often coding “other” for these variables. This ana-
lysis is limited to New York City, which is racially and ethnically
diverse and a dense urban environment; thus, our findings may not
generalize to other areas. Finally, many parts of New York City
are on islands, and edge effects may have affected our geospatial
results.
If  patients with high diabetes-related health care expenditures,
morbidity, and mortality develop diabetes at an early age and are
unlikely to obtain medical care, then the public health approach to
screening for type 2 diabetes may need to be revised. Given clus-
tering of poor outcomes in certain neighborhoods, community-
based diabetes screening may be an approach that increases aware-
ness among groups unlikely to access medical care and would ex-
pand diagnosis outside of clinical settings (33). Doing so, we may
be able to develop and deliver high-yield and culturally relevant
interventions that can reduce these disparities.
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Table
Table. Demographic Characteristics of New York City Population,a Unique Emergency Department Patients,b and Emergency Department Patients With Type 2 Dia-
betes
Characteristic
Census Estimates, % (N =
7,388,165)
Unique Emergency Department
Patients, % (N = 5,556,650)
Emergency Department Patients
With Type 2 Diabetes, % (N =
576,306)
Age group, y
10–19 12.9 13.4 0.5
20–29 19.0 21.6 2.2
30–39 17.8 17.6 5.1
40–49 15.4 14.1 12.4
50–59 14.4 13.0 22.5
60–69 10.7 9.1 23.5
70–79 5.9 5.9 18.8
≥80 4.0 5.3 15.0
Sex
Male 47.6 45.1 45.4
Female 52.4 54.9 54.6
Race/ethnicity
Non-Hispanic white 32.5 22.6 20.2
Non-Hispanic black 22.4 28.9 32.8
Hispanic 28.9 26.4 24.8
Asian 13.4 6.0 6.6
Other 2.8 16.1 15.6
Health insurance
Private 47.2 27.1 15.7
Medicare 12.0 13.7 41.0
Medicaid 24.1 36.5 32.1
Self-pay 12.4 18.4 8.3
Other 4.3 4.3 2.9
a Data source: American Community Survey 2011–2015 (19).
b Data source: New York State Department of Health Statewide Planning and Research Cooperative System (18).
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